<?xml version="1.0" encoding="UTF-8"?>
<ref id="dkx118-B33">
 <label>33</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Raffi</surname>
    <given-names>F</given-names>
   </name>,
   <name name-style="western">
    <surname>Jaeger</surname>
    <given-names>H</given-names>
   </name>,
   <name name-style="western">
    <surname>Quiros-Roldan</surname>
    <given-names>E</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial</article-title>.
  <source>Lancet Infect Dis</source>
  <year>2013</year>;
  <volume>13</volume>: 
  <fpage>927</fpage>–
  <lpage>35</lpage>.
  <pub-id pub-id-type="pmid">24074642</pub-id>
 </mixed-citation>
</ref>
